play a role in tissue repair. In several tissues, including kidney, skeletal muscle, CNS neurons, aortic smooth muscle and endothelium there is an increase in local IGF-I expression after injury.
Since locally produced IGF-I may play a role in the natural regenerative process and as administration of recombinant IGF-I enhances recovery from ischemic ARF, we set out to characterize the changes in the renal GH-IGF-I system following acute ischernie renal failure. This system includes IGF-I, six insulin-like growth factor binding proteins (IGFBP) and the receptors for IGF-I and GH [12, 14] . The binding proteins, also present in the circulation, have a high affinity for IGF-I and serve as a carrier or reservoir for the hormone and modulate its bioactivity [16, 17] . We reasoned that information from our study would provide new insight into the role of IGF-I in the restoration of renal structure and function, and assist in the design of rational therapeutic approaches for the use of IGF-I in the treatment of acute renal failure. To this end we have utilized a rat model of ischemic acute renal failure.
Methods

Animals
Male Sprague-Dawley rats weighing 250 to 300 g were anesthetized with sodium methohexital 50 mg/kg body weight i.p. The kidneys were then exposed via a flank incision. In half the rats the renal pedicle was clamped; the other rats served as a shamoperated control group. The wounds were then covered with gauze. After 60 minutes the clamps were removed and the wounds of all the animals were suture closed. Rats were returned to their cage and allowed ad libitum access to food and water. Dietary intake in these rats was not controlled since we wished, as a first step, to characterize the renal response in a model that simulates the clinical situation. Serum creatinine was measured in tail vein blood. Experimental rats that did not achieve a serum creatinine above 2 mg/dl after two days were excluded from the study. Rats were sacrificed under anesthesia two or seven days after surgery. For rnRNA analysis kidneys were rapidly excised, blotted and frozen in liquid nitrogen. For measurement of kidney IGF-I content and receptor binding analysis, kidneys were saline perfused via the aorta until free of blood. In another set of experiments weight matched sham operated controls and ATN rats were pair fed to control for any response due to the reduced dietary intake that accompanies uremia. These rats were studied two days after injury.
Preparation of "crude" kidney plasma membranes Tissues from one and a half whole kidneys were minced, added to cold 8% wt/wt sucrose buffer and then disrupted with 15 gentle strokes in a dounce homogenizer. The homogenate was centrifuged at 1000 g for 10 minutes and the supernate collected. The pellet was disrupted with 10 strokes in a homogenizer containing 10 ml sucrose buffer and then centrifuged at 1000 g for 10 minutes.
The supernates were pooled and spun at 9,500 g for 10 minutes. The supernate and soft light upper pellet were removed from the central dark pellet and then mixed prior to centrifugation at 47,000 g for 20 minutes. The soft light fluffy upper pellet was removed and resuspended in 1 ml calcium free Krebs-Ringers Hepes (KRH) buffer and washed twice and stored at -80°C until use. All steps were carried out at 4°C.
IGF-I binding assays
Recombinant hIGF-1, a gift from Genentech Inc. (South San Francisco, CA, USA), was radiolabeled with 1251-Na (< one iodine atom/molecule) by a chloramine T method [181. The binding of 1251-IGF-I to crude kidney plasma membranes was determined as follows. Calcium-free KRH buffer containing 0.5% BSA with or without various concentrations of unlabeled IGF-I and other cold peptide hormones were added to the same buffer containing 10_Il M '251-IGF-I and 2 mi bacitracin and 5 m N-ethylmaleimide. The membrane suspension containing 60 tg of protein was then added and incubated at 4°C overnight. Membrane-bound and free 1251-IGF-I were separated by centrifugation at 12,000 g for 15 minutes and the supernatants aspirated. The membrane pellets were washed once with the KRH buffer and the tips of the centrifuge tubes excised. '251-radioactivity was determined in a gamma counter. Nonspecific binding was defined as the counts of '251-IGF-I remaining associated with membranes in the presence of 10_6 M of unlabeled IGF-1, and is subtracted from total binding to yield specific binding. With 1251-IGF-I nonspecific binding averaged 1.9 0.18%. The data from competition curves were subjected to Scatchard analysis to determine binding affinity and receptor number [19] . 1251-IGF-I degradation in the binding assays was assessed as the appearance of radioactivity soluble in 10% trichloroacetic acid (TCA) and averaged 4.3% of total counts.
Cross linking of '251-IGF-I receptor '251-IGF4 was cross linked to kidney membranes essentially as described by Pillion, Haskell and Meezan [201. Aliquots of crude membrane preparations equivalent to 200 jg of protein were incubated overnight at 4°C with 10_b M radiolabeled I-IGF-I in the absence or presence of i0-M unlabeled IGF-I or insulin. The membranes were washed twice in BSA-free Krebs-Ringers Hepes buffer (KRH), pH 7.5. Cross linking of the alpha1 subunit of IGF-1 receptor was allowed in KRH in the presence of 0.25 mM disuccinimidyl suberate at 4°C for 15 minutes. The cross linking was terminated by the addition of 10 ifiM Tris-HCI with I ifiM EDTA, pH 7.5. The pellets were washed twice and were resuspended in 20 p.! of sample buffer in the presence of 1% 2-mercaptoethanol as a reducing agent, heated at 95°C for 90 seconds, and subjected to 5 to 15% gradient SDS-polyacrylamide gel electrophoresis. The radioactivity in the gel was analyzed by autoradiography. Molecular weights were determined by comparison with prestained markers from BioRad (Richmond, CA, USA).
Western ligand blot
Plasma membranes were prepared from saline perfused bloodless whole kidneys as described earlier. Membrane protein, 60 p.g, pooled from five rats was electrophoresed in 12% polyacrylamide gel. Separated proteins were electroblotted onto nitrocellulose filters with a BioRad Semi-Dry Transfer Cell and then incubated with a mixture of 1251-IGF-I and '251-IGF-II overnight at 4°C and visualized by autoradiography [21] . Cytosolic protein (10,000 g supernate) was also examined in the same manner, but no signal was detected with 100 p.g cytosolic protein.
Estimation of serum and kidney concentrations of IGF-I using RIA IGF-1 was extracted from serum and bloodless saline perfused kidneys before measurement by radioimmunoassay. Before harvesting, kidneys were briefly perfused with saline in vivo to render them blood free. The extraction method used was based on that described by D'Ercole, Stiles and Underwood [22] and acidseparates IGF-I from its binding proteins. This procedure gives values comparable to that obtained following high pressure liquid chromatography separation [23] . A quarter of a kidney from each rat was homogenized in 1 M acetic acid and the acid extract Preparation of RNA Total kidney RNA was isolated using the single step method of Chomczynski and Sacchi [24] . A quarter of a kidney from each rat was homogenized, and RNA was extracted using acid guanidinium thiocyanate-phenol-chloroform and then spectrophotometrically quantified by determining absorbance at 260 nm. The integrity of RNA was checked by inspecting the fluorescence of ethidium bromide stained I 8S and 28S rRNA bands separated by agarose gel electrophoresis.
Solution hybridization/RNase protection assay
Protection assays were performed as previously described [25] . Total RNA (20 p.g) was hybridized with 100,000 cpm of a-32P CTP labeled antisense IGF-I or IGF-I receptor riboprobes and 5,000 cpm of antisense GAPDH riboprobe for 14 hours at 55°C in 80% formamide/400 mivi NaCl buffer. After hybridization, the mixture was digested with ribonuclease A (10 p.g/ml) and ribonuclease Ti (100 U/mI) at 37°C for 30 minutes and then proteinase K (200 p.g/ml) at 37°C for 30 minutes, Protected hybrids were size-separated on a 5% polyacrylamide/8 M urea denaturing gel and analyzed by autoradiography.
Northern blot analysis
Total RNA was size-separated by agarose gel electrophoresis. Briefly, RNA was denatured with 0.55 M formaldehyde. Twelve micrograms of RNA was loaded in each lane and electrophoresed on a denaturing agarose gel containing 0.55 M formaldehyde.
RNA was transferred by capillary action onto nitrocellulose filters and then fixed to the filters by UV cross linking (UV 1800
Stratalinker; Stratgene, La Jolla, CA, USA). The filters were then prehybridized in the hybridization solution (50% formamide, 1.5 X SSPE, 2.5 x Denharts solution, 50 jg salmon sperm DNA, 0.2% SDS) at 42°C for two hours. The mRNA levels of IGFBP-1, -2, -3, -4, and -5 were detected by hybridizing radiolabeled cDNA probes to the mRNA. Probes, -2.5 million cpmlml, were hybridized to the respective mRNAs on Northern blots in a fresh hybridization solution at 42°C overnight. The filters were then washed and exposed to Kodak XAR films (Kodak, Rochester, NY, USA) at -70°C for one to five days. Where noted the filters were then reprobed with a hGAPDH eDNA probe. The mRNA abundance of each IGFBP was analyzed by densitometry (Ultrascan XL, Pharmacia LKB Biotechnology, Inc., Alameda, CA, USA) and corrected for either the levels of the GAPDH mRNA readings or the I 8S mRNA readings obtained from photographic negatives of the nitrocellulose filters. In preliminary experiments we found that GAPDH mRNA levels in kidneys two and seven days post-ischemia did not differ from that measured in shamoperated control kidneys. A linear relationship was present between the optical density (OD) of the photographic negative of the nitrocellulose 18S mRNA signal and the total RNA content up to 30 jg (r = 0.99).
Polymerase chain reaction (PCR) assay
Relative levels of renal GH receptor mRNA were assayed by using a gene Amp RNA-PCR kit (Perkin Elmer Cetus, Norwalk, CT, USA) [26] . Total RNA was reverse transcribed by using random hexamers. The oligonucleotide primers for the GH receptor were designed to amplify a 321 base pair DNA fragment. The fragment included 97 bases in exon 5 and 145 bases in exon 7. Both exons are in the extracellular domain of the rat GH cDNA sequence [27] . GH receptor mRNA was amplified by 28 PCR cycles and as an internal amplification control, 18S rRNA was amplified in the same assay tube for the last 10 cycles by adding specific 18S rRNA primers. The 18S rRNA primers amplified 140 bases spanning nucleotide positions 107 to 246 in the human cDNA sequence [28] . PCR products were separated on a 5% polyacrylamide!8 M urea gel and analyzed by quantitative autoradiography.
Preparation of radiolabeled probes For the solution hybridization/RNase protection assay, labeled antisense IGF-I, IGF-I receptor and GAPDH riboprobes were synthesized using 32P-labeled CTP as previously described [25] .
The IGF-I riboprobe, a 376 bp Sau3A-EcoRI fragment was designed to detect both the Ea and Eb IGF-I mRNAs [29] . The IGF-I receptor riboprobe contained 280 bases complementary to the IGF-I receptor mRNA. For Northern blot analysis the eDNA probes were labeled with 50 tCi [32P] dCTP (3000 Ci/mmol, Amersham, Arlington Heights, IL, USA) by a random primer method (DNA labeling kit 70200; United States Biochemical Corporation, Cleveland, OH, USA). Radiolabeled cDNA probes were purified by centrifugation through a G-50 Sephadex column.
The cDNA probes for the five IGFBPs studied were derived from rat cDNAs cloned into recombinant plasmid vectors (pBluescriptSK+) which were gifts of Dr. S. Shimasaki (Whittier Institute, La Jolla, CA, USA). The probes were obtained by synthesizing the corresponding cDNA by PCR using the cloned cDNA as a template. The molecular characteristics of the rat cDNAs have recently been reviewed by Shimasaki and Ling [30] . The IGFBP-1 probe comprised 407 bp corresponding to the coding 
Data analysis
Densitometry readings of the mRNAs of interest were corrected for the corresponding GAPDH mRNA or 18S RNA reading. For IGF-I we quantified the Ea IGF-I mRNA transcripts only since it accounted for >95% of the IGF-1 mRNA signal. Results are expressed as the mean SEM. The mean of the controls was assigned a value of unity and all results were expressed in relation to this value. Differences between the control and experimental groups were evaluated using Student's two-tailed unpaired t-test. P values of <0.05 were considered significant.
Results
Ad libitum fed rats Following bilateral renal pedicle clamping the serum creatinine rose, reaching a maximum after 24 hours. After the second day the serum creatinine, which averaged 4.2 0.32 mg/dl, declined (Fig.  1) . By the seventh day serum creatinine levels had fallen considerably but were still more than double the baseline values (1.0 0.4 vs. 0.4 0.04 mg/dl). Changes in body weight differed significantly (P < 0.01) between the two groups after the experimental intervention (Table 1) . Two days post-injury ATN rats lost 27 g while the body weight of the controls had not changed. On When measured on day 2 after surgery, specific IGF-I binding to kidney membranes from postischemic rats was twofold greater than the controls (13.9 1.6 vs. 7.7 0.4%/60 g protein, P < 0.01). On day 7 there was a similar increase in binding to the post-ischemic membranes (14.6 1.3 vs. 8.1 0.4%, P < 0.01). It is notable that the extent of specific IGF-I receptor binding correlates significantly with the serum creatinine levels measured on day 2 (Fig. 3) . This suggests that the degree of injury may have day 7, the ATN rats were still 17 g below their starting weights, while control rats had gained 25 g.
For the IGF-I receptor binding study, we first tested the specificity of ligand binding to normal rat kidney membranes. We Figure 4 . When the data were expressed as a percent of maximum 1251-IGF-I bound, the displacement curves were superimposable (Fig. 4 insert) . These curves were used to determine the concentration of recombinant IGF-I at which 1251-.IGF4 binding was 50% of maximum, a measure of relative receptor affinity. For control and experimental membranes from day 2 and 7 this averaged 2 and 1.4 nM, respectively. These findings suggest that receptor affinity was similar in these two groups. Scatchard analysis of the high affinity binding components revealed that receptor affinity (0.4 nM) was the same in both groups, while receptor number was increased more than twofold following ATN compared to the controls (125 vs. 54 pM/60 g membrane protein). The specificity of IGF-I receptor binding in control and postischemic membranes was further demonstrated by IGF-I receptor covalent cross linking experiments. The autoradiogram depicted in Figure 5 shows 1251-IGF-I bound to a protein of Mr -130 kDa which is compatible with the alpha1 subunit of the IGF-I receptor. Binding was blocked by iO M IGF-I, but not by insulin. While both sets of membranes were exposed to the same '251-IGF-I concentration, labeling of the ATN membranes was more intense, in keeping with a greater number of receptors in the ATN membranes.
In contrast to the change in receptor protein number there was no significant difference in relative IGF-I receptor mRNA abundance in post-ischemic kidneys compared to controls two or seven days after surgery (Fig. 6 ). This indicates that the increase in IGF-I receptor number in the injured kidneys is a consequence of post-translational up-regulation.
The results of the analysis of kidney IGF-I mRNA levels are shown in Figure 7 . In post-ischemic kidneys steady-state IGF-I mRNA abundance was significantly reduced on day 2 and averaged 21% of the control value. By day 7 relative mRNA abun- dance had returned to control values. Since kidney production of IGF-I is in part regulated by Gil [13] , we studied GH receptor gene expression in the ATN kidney two and seven days after the ischemic injury. As shown in Figure 8 , relative GH receptor mRNA abundance was significantly diminished in the injured kidneys. On days 2 and 7 the ATN values were on average 9 and 35% of their respective control values.
Next we measured tissue and serum levels of the IGF-I protein by radioimmunoassay. Serum IGF-I concentrations measured on days 2 and 7 were similar in the two groups of rats: 1001 100 versus 941 46 and 893 70 versus 864 85 ng/ml, ATN versus control, respectively. These values are comparable to that reported in normal rats by others [11, 311 . Kidney immunoreactive IGF-I levels were measured on day 2 and were reduced significantly in the ATN kidneys compared to controls (5.15 0.56 vs. 7.47 0.44 ng/mg protein, P < 0.01). This is consistent with the reduced kidney IGF-I mRNA levels observed in this group.
Since IGFBPs modulate IGF-I action, we measured the relative mRNA abundance of IGFBP-1, -2, -3, -4 and -5 from postischemic and control rats. Results are depicted in Figure 9 . As compared to controls, the mRNA levels of IGFBP-1 was unchanged. In contrast the abundance of IGFBP-2, -3, -4 and -5 fell significantly in the injured kidneys on day 2. The average value of these IGFBP mRNAs in the ATN group ranged between 4 and 62% of their respective control values. This was followed by recovery which for IGFBP-3 and IGFBP-5 was still incomplete on day 7. Western ligand blot analysis of kidney plasma membranes demonstrated two IGFBPs of molecular weight approximately 24 and 30 kDa each (Fig. 10) . The signals for both proteins were reduced in the membranes prepared from rats two days after injury. The OD of the 24 kDa protein averaged 0.32 and 0.14 arbitrary units in the control and ATN groups, respectively. The corresponding values for the 30 kDa protein averaged 0.48 and 0.17 arbitrary units, respectively. This represents a 56 and 65% reduction of the 24 and 30 kDa proteins in ATN.
Pair fed rats The extent of the renal failure in these experiments judged by the serum creatinine levels two days after ischemic injury was comparable to that seen in the ad libitum fed animals ( Table 1) . Body weight changes in ATN and pair fed controls were similar. As noted in the ad libitum experiments kidney IGF-I receptor mRNA levels, depicted in Figure 11 , did not change while plasma receptor binding increased significantly in the ATN group (20.8 0.77 vs. 8.7 0.67%160 jsg protein; P < 0.01). Steady-state IGF-I mRNA levels were reduced significantly in the ATN group and averaged 37% of the pair fed control value (Fig. 11) . GM receptor mRNA abundance was reduced to 11% of the control value (Fig.  11) . As shown in Figure 12 there were marked changes in the fell significantly after the ischemic episode to values ranging between 13 and 67% of controls. There was no significant change in IGFBP-1 mRNA levels.
Discussion
In this study we have demonstrated that acute ischemic kidney injury is followed by profound alterations in the renal GH-IGF-I system. These changes were not related to food consumption for similar patterns were seen whether dietary intake was ad libitum or controlled. We found that two days after the injury, kidney IGF-I mRNA levels had declined to approximately 20% of the value seen in sham-operated control animals allowed free access to food and water. Kidney immunoreactive IGF-I concentration was also reduced at this time. After seven days the mRNA levels had returned to values similar to those measured in the controls. Presumably the low IGF-I mRNA levels together with the reduced IGF-I protein levels indicate that local IGF-I production is reduced at this time when IGF-I would be of particular value in the reparative process. In contrast to the fall in kidney IGF-l concentration the number of IGF-I specific receptors in the by quantitative PCR. The relative GH receptor mRNA levels were calculated as described in Fig. 6 with the 18S RNA signal substituting for GAPDH. N = 4 to 6 rats per time point. A representative autoradiograph from day 2 is shown. *p < 0.05, **p < 0.01.
kidney increased after the ischemic insult. However IGF-I receptor mRNA levels did not differ from control values. Thus the increase in receptor number appears to reflect a post-translational response. Also striking was the finding that IGFBP-2, -3, -4, and -5 mRNA levels were markedly reduced. Indeed two days after injury the average of these IGFBP mRNA levels ranged between 4 and 62% of their control values. This was accompanied by a decrease in plasma membrane associated IGFBPs. While this is consistent with decreased IGFBP production, post-translational events such as increased proteolytic destruction may also play a role. By the seventh day, IGFBP-2 and -4 mRNA levels had returned to control values. As discussed later, the reduction in IGFBP gene and protein expression could conceivably result in an increase in the bioavailability of the free circulating IGF-I that enters the kidney. Our finding of a decrease in immunoreactive IGF-I levels in the damaged kidneys is consistent with Ding et a! [6] . On the other hand, Matejka and Jennische [32] , using a non-quantitative morphologic approach, observed that in rats following ischemic injury the renal distribution of IGF-I became more widespread. IGF-I immunoreactivity was not limited to the collecting ducts and loop of Henlé as is seen in normal rat kidneys [12, 33, sized locally and IGF-I bound to receptors. Our finding of an increase in receptor number supports the latter hypothesis. Sequestration of IGF-I by local IGFBPs provides another potential mechanism for increased local immunoreactivity. However, the marked decrease in kidney IGFBP mRNA levels together with the decrease in kidney IGFBP proteins that we noted argues against but does not exclude this mechanism.
While interruption of renal blood flow with its attendant ischemic injury is the initiating event for the observed changes in the renal IGF-I system, proximate signals mediating these changes were not examined. Nevertheless, it is worth considering potential mechanisms involved in these changes. In respect to IGF-I receptor binding, it appears that the increase in receptor density represents a post-transcriptional event since there is no corresponding change in mRNA level. Among the possibilities are an increase in mRNA translation, increased receptor stability or even a redistribution of cellular receptors from an intracellular location to the cell surface [35] . Initially the increase in receptor density could be a response to a decrease in kidney IGF-I production seen early after injury. The increase in receptor number cannot be accounted for by reduced food intake [36] since a similar response was seen when controls were paired with the ATN rats. Interestingly, there was a strong correlation between peak serum creatinine levels measured on day 2 and IGF-1 receptor binding measured two and seven days after the ischemic insult; this suggests a direct link between the extent of the renal injury and the receptor response. Up-regulation of receptor number will likely favor the renal action of circulating and local IGF-I. Why kidney IGF-I mRNA levels fall after ischemic injury is an intriguing question since the brunt of the ischemic injury involves the proximal tubule, a nephron segment where IGF-I is not normally produced. It is likely that the reduced IGF-I mRNA levels reflect dysfunction of the cells in the medullary ascending limb of Henlé and collecting ducts that normally produce IGF-I [13, 34, 37] . Indeed, while the major site of ischemic injury is the proximal tubule, less obvious morphologic changes are present in these more distal nephron segments [38] . This injury probably accounts for the reduction in IGF-I mRNA levels which may reflect reduced mRNA production or stability.
Interestingly kidney preproEGF mRNA levels, also expressed in the ascending loop of Henlé and distal tubule, decline following ischemic injury [39] . Since EGF stimulates collecting duct IGF-I gene expression [40] , reduced kidney EGF production could account, in part, for the reduced IGF-I mRNA levels. Growth hormone is another potent regulator of kidney IGF-I production [13] . We found that kidney GH receptor mRNA levels are reduced in ischemic ATN, and thus propose that reduced GH signaling may also be a factor accounting for the low kidney IGF-I mRNA levels. This likely explains the failure of GH therapy to influence the course of acute ischemic renal failure in rats [51.
Note that the GH receptor mRNA levels were measured with a primer set that amplified a portion of the rat cDNA which encodes most of the extracellular domain of the receptor which is identical to the corresponding part of the serum GH-binding protein [27] . In the rat there is an alternative splicing event during the processing of the complete GH receptor mRNA. The IGFBPs are important, but poorly understood, components of the renal IGF-I system [14] . Six IGFBPs have been identified and all are expressed in the kidney [30] . Of these binding proteins, the site of renal production has only been 
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Relative mRNA levels of IGFBP-1, -2, -3, -4, and -5 in kidneys from 5 pair-fed control and 5 A TN rats two days after injwy. mRNA levels were detected by Northern blot analysis and corrected for the 18S RNA levels. Results were analyzed and expressed as described in Fig. 6 . Representative Northern blots from control (VA) and ATN (El) rats respectively are shown.
< 0.01.
the IGFBPs is unclear, but they do bind IGF-I with very high not stored in IGF-I producing cells. While the IGFBPs may affinity and may serve as carrier delivering IGF-I to the target cells inhibit IGF-I action by reducing bioavailability, under selective [16, 171 . The IGFBPs may also serve as a circulating and tissue conditions some of the IGFBPs may actually enhance IGF-I reservoir for IGF-I. This is potentially important since IGF-I is action [17] . Little is known about the action of the IGFBPs in the kidney. However, in preliminary studies with cultured rabbit proximal tubular cells we have found that the IGFBPs produced by these cells and as well as recombinant human IGFBP-3 inhibit IGF-I action [42] . Taking together what little is known about the actions of IGFBPs we offer for consideration the possibility that the overall effect of reduced IGFBP mRNA and protein levels in ischemic ATN may result in an increase in the bioavailability of IGF-I. While this study offers fresh insight into the response of the renal GH-IGF-I axis to acute ischemic injury, it should be recognized that the study was conducted at the whole kidney level and thus reflects net changes in the kidney so that local changes may be masked. Nevertheless, when interpreting these results important general conclusions can be made which will serve as the basis for further mechanistic studies into the local response to acute tubular cell injury. Of particular interest are the observations that whole kidney mRNA levels for IGF-I and also several IGFBPs are reduced, that kidney plasma membrane associated IGFBPs are reduced and that kidney IGF-I receptor density is increased. Taken together we propose that the low kidney IGF-I mRNA levels in combination with the reduced kidney IGF-I protein levels indicate an overall decrease in kidney IGF-I production. This IGF-I deficiency will not favor tissue repair. On the other hand, we offer for consideration the suggestion that reduced kidney IGFBP gene expression with reduced IGFBP protein levels together with an increase in IGF-I receptor number might serve to offset the lowered kidney IGF-I production and also enhance the reparative actions of circulating endogenous or exogenous administered hormone.
